Effect of aficamten compared with metoprolol in women versus men: analysis of MAPLE-HCM

10 May 2026 (14:57 - 15:06)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Xiaowen Wang

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail

Mavacamten to treat patients with obstructive HCM in Portugal: an interim analysis of the MAVA-PT cohort

Doctor D. Da Silva Correia (Lisbon, PT)

Presentation thumbnail

The influence of QRS duration and resynchronization status on the efficacy and safety of omecamtiv mecarbil in heart failure with reduced ejection fraction: the GALACTIC-HF trial

Assistant Professor M. Ruppert (Boston, US)

Abstract Slides Video

Presentation thumbnail

Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials

Doctor G. Mendieta Badimon (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Ferric carboxymaltose modulates metabolic and inflammatory pathways alongside erythropoiesis in heart failure: mechanistic insights from the AFFIRM-AHF

Doctor N. Grote Beverborg (Groningen, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Novel and targeted therapies: precision pharmacology in heart failure

The Event

Event poster

Heart Failure 2026

10 May 2026 14:57 CET

You may be interested in

Congress Presentation

Dose-dependent effects of aficamten vs metoprolol in MAPLE-HCM

Congress Presentation

Effect of Aficamten Compared with Metoprolol on Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy: A pre-specified analysis of MAPLE-HCM

Congress Presentation

Heart failure in men and women: is it different?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources